about us | newsletter | contact | archive | members area
"I think investors should discover and consider Moldova as a target region"
Radu Craciun, BCR Pensii»
  News:      POLITICS   |   ECONOMICS   |   ENERGY   |   INVESTMENTS   |   APPOINTMENTS   |   GREEN   |   INFRASTRUCTURE   |   REAL ESTATE   |   AGRIBUSINESS   |   DRIVING   |   CITY LIFE   |   EVENTS   |

Sanofi transferred drug production and packaging for 22 medicine brands to Romanian facility

French pharmaceutical group Sanofi transferred the packaging and production operations for 22 drug brands to Zentiva plant in Romania, while 30 other products run various transfer stages, the company announced.

2014-05-05 17:08:13

Within the 22 drug products transferred in 2013, 15 drugs are completely produced while for other seven, the company runs the packaging process. In 2013, the producer attained exports for 25 drug products, representing 133 pharmaceutical features in countries such as: France, Germany, Great Britain, Italy, Bulgaria, Czech Republic, Slovakia and Hungary.

The exports achieved by Zentiva facility attained 19 percent within the overall sales in 2013, compared to only 7 percent in 2012. The largest exports have been managed for Germany with 5.3 million lei, France with 26.2 million, Italy with 7.8 million, besides Poland, Portugal and Czech Republic. Out of 112 drug products for humans, including 107 medicine products and 5 natural supplement products, 77 percent are produced in Romania and 23 percent are produced in Sanofi Zentiva facilities outside the country.

In 2013, the company announced it invested EUR 2.9 million for new production equipments and upgraded to existing ones. For 2014, the company plans to increase by 18.6 percent the net profit, to reach EUR 10.7 million (47.8 million lei). In 2013, Zentiva announced a profit worth EUR 9.1 million (40.3 million lei), 25 percent up compared to 2012. Also, the company turnover reached EUR 65.8 million (291 million) in 2013, 20 percent more compared to previous year. According to latest data, Sanofi-Aventis owns 81.6 percent from Zentiva stock of shares.

In 2013, Zentiva numbered 483 employees, 67 down comoared to 2012. The French group Sanofi-Aventis is second largest on the Romanian market, with 7 percent market share and sales worth 827.5 million lei. The top medicine producer in Romania is Roche Group, according to a Cegedim ranking.



COMMENTS
There are 0 comments:

 
ADD A COMMENT
 
Name
Email
Comment
Validation Code
   
 
 

0 Comments  |  3149 Views
Daily Info
AFI Europe Romania posts net operating income of over 37 million Euro in the first nine months

AFI Europe Romania published its financial results, with the net operating income from its income producing assets in Romania of over 37 million Euro in the first nine months ...

Openville Timisoara to open in the fourth quarter of 2018

The Openville Timisoara development, the largest mixed-use project in the west of Romania will be opened in the fourth quarter of next year, upon completion of the first phase...

URBB posts record production figure in 2017

United Romanian Breweries Bereprod (URBB) registered a record production figure exceeding two million hectolitres for the period January-November 2017, representing a 10 per c...

Cristian Busu has been reappointed president of Electrica's board

Cristian Busu has been reappointed president of Electrica board, the electric energy supplier. He is a member of the board since 2014 and was chosen in this position during th...

Transelectrica inaugurated the Campia Turzii station, fully refurbished with 9 million Euro

Transelectrica inaugurated the 220/110/20 kV Campia Turzii (Cluj County) electricity station, after an investment of about 42 million RON (9 million Euro).

 
 
   
advertising

advertising

advertising

advertising

advertising

advertising

advertising

More on News
Minister Negrescu: Romania is profoundly pro-European, we will be even more significant after Brexit completion

Minister Delegate for European Affairs Victor Negrescu said on Thursday that Romania is a profoundly pro-European state and will become more significant after the Brexit pr...

Iohannis: A significant delay in tax measures would be required

President Klaus Iohannis said that a significant delay in the amendments to the tax legislation would be required, adding that the January 1, 2018 deadline for their applic...

Dragnea: Amendments to the tax code, code of tax procedure to pass under government ordinance

Amendments to the tax code and the code of tax procedure will pass under a government ordinance and will be unveiled after the government meeting, national leader of the So...

Iohannis: Romania has made progress with equal opportunities, needs to speed up gap bridging

Romania's President Klaus Iohannis said that although important progress has been made in Romania in terms of gender equality, the country needs to speed up bridging the ga...

PM Tudose: We will shortly come up with new form of split VAT collection

A new form of split VAT collection, which will respond to the requests made in this period by business representatives, will be presented shortly, Prime Minister Mihai Tudo...

Iohannis: Advanced presence on Eastern Flank must be reinforced, especially in Black Sea

President Klaus Iohannis stated on Monday that the advanced presence on NATO's Eastern Flank must be reinforced.

MAE requests Ukraine to adopt necessary measures so that Romanians learn in their mother tongue

The Foreign Affairs Ministry (MAE) announced that it will continue to take steps with the international authorities to signal the negative impact of the legislative amendme...